New standards may help push more drugmakers to use a synthetic product for critical drug safety testing, instead of one made from horseshoe crab blood that has long drawn criticism. The U.S.

In this episode of C&EN Uncovered, host Craig Bettenhausen speaks with C&EN assistant editor Laurel Oldach about the use of horseshoe crab blood in pharmaceutical endotoxin testing, the challenges of ...

It’s a bad week for horseshoe crabs as their defenders have failed to convince big pharma that synthetic crab blood is a viable alternative for endotoxin testing in drugs. Maryland-based US ...

Hundreds of thousands of horseshoe crabs are used for endotoxin testing in the United States each year, bled for their blood’s ability to clot in the presence of toxins. An estimated 10 to 30 percent ...